Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease Research
These studies contribute to the broader AMP PD initiative by providing the research community with a harmonized proteomics dataset. As part of the larger AMP PD data, this work provides the PD community with a harmonized and accessible proteomics dataset that can be utilized for discovery, hypothesis generation, and validation of users' own research. © 2026 Technome. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Authors
- Preeti Bais (ORCID: https://orcid.org/0000-0002-3872-1650)
- Erin Teeple (ORCID: https://orcid.org/0000-0002-6294-1522)
- Jennifer Van
- Matt Bookman
- Victoria Dardov (ORCID: https://orcid.org/0000-0001-8771-2649)
- Maria S. Quinton
- Ameya Kulkarni (ORCID: https://orcid.org/0000-0003-4495-8838)
- David Vismer
- Rajaraman Krishnan (ORCID: https://orcid.org/0000-0002-5189-4097)
- Christine Swanson‐Fischer
- Guhan Nagappan
- Can Kayatekin (ORCID: https://orcid.org/0000-0002-4367-9645)
- Willy Nojopranoto
- Aparna Vasanthakumar (ORCID: https://orcid.org/0000-0003-3857-8812)
- Richard Hargreaves
- Sri Ramulu Pullagura
- Accelerating Medicines Partnership Parkinson's Disease (AMP PD) Proteomics Working Group
- Rakhi Pandey
- S. Pablo Sardi
- Niveda Sundararaman
- Barry Landin
Institutions
- Bristol-Myers Squibb (Germany) (DE)
- Smith College (US)
- Foundation for the National Institutes of Health (US)
- Michael J. Fox Foundation (US)
- AbbVie (United States) (US)
- Bristol-Myers Squibb (United States) (US)
- VERN' University (HR)
- National Institute of Neurological Disorders and Stroke (US)
- Sanofi (United States) (US)
- Applied Engineering Management (United States) (US)
- Cedars-Sinai Smidt Heart Institute (US)
Publication Details
- Journal
- Movement Disorders
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1002/mds.70183
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Foundation for the National Institutes of Health
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- Celgene
- Australian Government
- Verily Life Sciences
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke